| Schedule of Segment Reporting |
Selected financial information for the
Company’s operating segments is as follows:
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
| Net revenues - External |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
645,386 |
|
|
$ |
2,240,170 |
|
|
$ |
1,407,976 |
|
|
$ |
3,471,072 |
|
| Supportive Software Solutions |
|
|
253,344 |
|
|
|
325,102 |
|
|
|
490,289 |
|
|
|
555,128 |
|
| |
|
$ |
898,730 |
|
|
$ |
2,565,272 |
|
|
$ |
1,898,265 |
|
|
$ |
4,026,200 |
|
| Net revenues - Intersegment (***) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Supportive Software Solutions |
|
|
206,167 |
|
|
|
237,993 |
|
|
|
284,493 |
|
|
|
534,341 |
|
| |
|
$ |
206,167 |
|
|
$ |
237,993 |
|
|
$ |
284,493 |
|
|
$ |
534,341 |
|
| (Loss) income from operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
(1,477,754 |
) |
|
$ |
(886,541 |
) |
|
$ |
(2,770,028 |
) |
|
$ |
(3,226,339 |
) |
| Supportive Software Solutions |
|
|
(342,348 |
) |
|
|
(1,234,194 |
) |
|
|
(1,060,894 |
) |
|
|
(2,547,507 |
) |
| Hospital Operations |
|
|
(553,352 |
) |
|
|
- |
|
|
|
(1,020,668 |
) |
|
|
- |
|
| Corporate |
|
|
(1,884,287 |
) |
|
|
(2,166,251 |
) |
|
|
(3,688,800 |
) |
|
|
(4,118,688 |
) |
| Eliminations |
|
|
330 |
|
|
|
33,664 |
|
|
|
8,181 |
|
|
|
67,324 |
|
| |
|
$ |
(4,257,411 |
) |
|
$ |
(4,253,322 |
) |
|
$ |
(8,532,209 |
) |
|
$ |
(9,825,210 |
) |
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
419,905 |
|
|
$ |
548,870 |
|
|
$ |
854,373 |
|
|
$ |
1,096,419 |
|
| Supportive Software Solutions |
|
|
45,421 |
|
|
|
162,059 |
|
|
|
202,984 |
|
|
|
326,487 |
|
| Hospital Operations |
|
|
6,609 |
|
|
|
- |
|
|
|
6,609 |
|
|
|
- |
|
| Corporate |
|
|
349 |
|
|
|
875 |
|
|
|
660 |
|
|
|
1,749 |
|
| Eliminations |
|
|
(330 |
) |
|
|
(33,663 |
) |
|
|
(8,181 |
) |
|
|
(67,324 |
) |
| |
|
$ |
471,954 |
|
|
$ |
678,141 |
|
|
$ |
1,056,445 |
|
|
$ |
1,357,331 |
|
| Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
- |
|
|
$ |
14,473 |
|
|
$ |
- |
|
|
$ |
6,000 |
|
| Supportive Software Solutions |
|
|
- |
|
|
|
7,881 |
|
|
|
- |
|
|
|
9,998 |
|
| Hospital Operations |
|
|
214,147 |
|
|
|
- |
|
|
|
1,305,069 |
|
|
|
- |
|
| |
|
$ |
214,147 |
|
|
$ |
22,354 |
|
|
$ |
1,305,069 |
|
|
$ |
15,998 |
|
*** Intersegment revenues are eliminated in consolidation.
| |
|
June 30, 2017 |
|
|
December 31, 2016 |
|
| Total assets |
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
2,195,239 |
|
|
$ |
3,986,126 |
|
| Supportive Software Solutions |
|
|
1,863,113 |
|
|
|
2,602,428 |
|
| Decision Support and Informatics |
|
|
- |
|
|
|
60,000 |
|
| Hospital Operations |
|
|
1,360,800 |
|
|
|
- |
|
| Corporate |
|
|
2,897,573 |
|
|
|
2,130,191 |
|
| Assets of AMSG classified as held for sale |
|
|
67,579 |
|
|
|
414,662 |
|
| Eliminations |
|
|
(2,696,985 |
) |
|
|
(2,711,014 |
) |
| |
|
$ |
5,687,319 |
|
|
$ |
6,482,393 |
|
|